These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
674 related articles for article (PubMed ID: 16095447)
41. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report]. Abballe C; Primieri P; De Cosmo G Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095 [TBL] [Abstract][Full Text] [Related]
42. [Nation-wide survey on muscle glycogen storage disease (MGSDs) and comparison with our experiences in diagnosis of MGSDs]. Fukuda T; Sugie H; Ito M; Sugie Y; Saito K; Nishino I; Shimizu T Rinsho Shinkeigaku; 2003 May; 43(5):243-8. PubMed ID: 12931628 [TBL] [Abstract][Full Text] [Related]
43. Carnitine palmitoyltransferase deficiency in a college athlete: a case report and literature review. Faigel HC J Am Coll Health; 1995 Sep; 44(2):51-4. PubMed ID: 7593992 [TBL] [Abstract][Full Text] [Related]
44. The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Capacchione JF; Muldoon SM Anesth Analg; 2009 Oct; 109(4):1065-9. PubMed ID: 19617585 [TBL] [Abstract][Full Text] [Related]
45. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States. Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB Anesthesiology; 2008 Apr; 108(4):603-11. PubMed ID: 18362591 [TBL] [Abstract][Full Text] [Related]
46. The myotonias and susceptibility to malignant hyperthermia. Parness J; Bandschapp O; Girard T Anesth Analg; 2009 Oct; 109(4):1054-64. PubMed ID: 19762732 [TBL] [Abstract][Full Text] [Related]
47. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia]. Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614 [TBL] [Abstract][Full Text] [Related]
48. Rhabdomyolysis Episode in an Individual with McArdle's Disease after Low Aerobic Exercise. Dantas GHM; Oliveira ALB; Marcos-Pardo PJ; Coutinho VFF; Sá Freire FC; Castro JBP; Souza Vale RG Saudi J Kidney Dis Transpl; 2022 Feb; 33(Supplement):S91-S99. PubMed ID: 37102530 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005. Brady JE; Sun LS; Rosenberg H; Li G Anesth Analg; 2009 Oct; 109(4):1162-6. PubMed ID: 19762744 [TBL] [Abstract][Full Text] [Related]
50. Drug-induced hyperthermia and rhabdomyolysis during the perioperative period: report of three patients. Vorrakitpokatorn P; Limsakul A J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S884-92. PubMed ID: 12452225 [TBL] [Abstract][Full Text] [Related]
51. McArdle's disease with late-onset symptoms: case report and review of the literature. Felice KJ; Schneebaum AB; Jones HR J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316 [TBL] [Abstract][Full Text] [Related]
52. [Muscle phosphorylase deficiency in childhood. A case report]. Bruno C; Iester A; Bado M; Morreale G; Broda P; Minetti C; Cordone A; Cordone G Minerva Pediatr; 1994 Oct; 46(10):459-62. PubMed ID: 7808367 [TBL] [Abstract][Full Text] [Related]
53. [Intraoperative hyperpyrexia in patients with osteogenesis imperfecta]. Fürderer S; Stanek A; Karbowski A; Eckardt A Z Orthop Ihre Grenzgeb; 2000; 138(2):136-9. PubMed ID: 10820879 [TBL] [Abstract][Full Text] [Related]
54. [MCARDLE'S DISEASE AND PHYSICAL ACTIVITY - A MIXED BLESSING]. Nemet D; Eliakim A Harefuah; 2021 Jun; 160(6):377-381. PubMed ID: 34160155 [TBL] [Abstract][Full Text] [Related]
55. McArdle disease or glycogen storage disease type v: Should it affect anaesthetic management? Ayerza-Casas V; Ferreira-Laso L; Alloza-Fortun MC; Fraile-Jimenez AE Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):101-3. PubMed ID: 25034937 [TBL] [Abstract][Full Text] [Related]